人瘤内免疫治疗(HIT-IT)临床试验开发的专家建议
2018年3月8日,ESMO在巴黎召开专家会议,由11位学术界专家、11位制药行业专家和2位ESMO代表临床医生参加,聚焦免疫刺激剂的瘤内注射/递送,旨在统一HIT-IT临床试验报告的标准术语和方法,提供参考文件指导临床研究者、药企、伦理委员会等,促进HIT-IT临床试验数量和质量提升。
要点
- 统一HIT-IT临床试验的标准术语和方法,确保质量保证并避免数据模糊。
- 强调系统性连续活检作为转化研究驱动因素的重要性。
- 需要记录和报告数据以更好理解关键过程。
核心结论
- 专家建议旨在统一HIT-IT临床试验报告的标准术语和方法,并提供参考文件指导相关方。
研究设计与样本
- ESMO赞助的专家会议于2018年3月8日在巴黎举行,包括11位学术界专家、11位制药行业专家和2位ESMO代表临床医生。
主要发现
- 会议聚焦免疫刺激剂的瘤内注射/递送,强调精确术语定义、系统性连续活检和数据记录报告的重要性。
临床怎么用
- 临床研究者、制药公司、伦理委员会、独立审查委员会、患者倡导者和监管机构可参考该文件指导HIT-IT临床试验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A European Society for Medical Oncology (ESMO)-sponsored expert meeting was held in Paris on 8 March 2018 which comprised 11 experts from academia, 11 experts from the pharmaceutical industry and 2 clinicians who were representatives of ESMO. The focus of the meeting was exclusively on the intratumoral injection/delivery of immunostimulatory agents with the aim of harmonizing the standard terms and methodologies used in the reporting of human intratumoral immunotherapy (HIT-IT) clinical trials to ensure quality assurance and avoid a blurring of the data reported from different studies. The goal was to provide a reference document, endorsed by the panel members that could provide guidance to clinical investigators, pharmaceutical companies, ethics committees, independent review boards, patient advocates and the regulatory authorities and promote an increase in the number and quality of HIT-IT clinical trials in the future. Particular emphasis was placed not only on the development of precise definitions to facilitate a better understanding between investigators but also on the importance of systematic serial biopsies as a driver for translational research and the need for the recording and reporting of data, to facilitate a better understanding of the key processes involved.
引用
- Marabelle A, Andtbacka R, Harrington K, et al. Starting the fight in the tumor: expert recommendations for the development of human intratumoral immunotherapy (HIT-IT). Ann Oncol. 2018. PMID: 30295695. doi:10.1093/annonc/mdy423
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。